Definitive Contract HHSN272201700078C

Ended Awarded Last action

Contract number
HHSN272201700078C
Awardee
Awarding agency
Obligated
$329,835,681

Award facts

Opportunity
Contract value 99% obligated
  • $329,835,680.79 Current, with exercised options
  • $332,437,171.79 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Negotiated Proposal / Quote
Pricing
Cost Plus Award Fee
Place of performance
Cape Fear, NC 28401, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00031 · Niaid HIV and other infectious diseases clinical research support services (CRSS) -$9,841,644
Funding Only Action P00030 -$23,597,169
Funding Only Action P00029 -$25,965
Exercise an Option P00028 $9,742,785
Funding Only Action P00027 -$60,357
Funding Only Action P00026 -$150,755,080
Exercise an Option P00025 $9,475,390
Other Administrative Action P00024 · To provide a broad range of clinical and other related research support services for ACTIV2 clinical trial. Also provide a broad range of clinical and other… $0
Exercise an Option P00023 $653,131
Funding Only Action P00022 $3,514,305
Funding Only Action P00021 · "covid 19". To provide a broad range of clinical and other related research support services for ACTIV2 clinical trial. Also provide a broad range of clinical… -$3,514,305
Other Administrative Action P00020 $0
Funding Only Action P00019 -$269,864
Exercise an Option P00018 $291,508,796
Funding Only Action P00017 -$36,187,451
Funding Only Action P00016 -$1,058,924
Funding Only Action P00015 · "covid-19". To provide a broad range of clinical and other related research support services for ACTIV2 clinical trial. $131,500,653
Other Administrative Action P00014 · The purpose of this contract is to continue to provide a broad range of research support services to the current and evolving daids supported research… $0
Funding Only Action P00013 $8,872,517
Funding Only Action P00012 -$8,872,517
Exercise an Option P00011 · "covid-19" to provide a broad range of clinical and other related research support services for ACTIV2 clinical trial, an operation warp speed project. $68,805,594
Exercise an Option P00010 · Provide a broad range of clinical and other related research support services for daids-supported clinical research programs and projects as well other… $9,193,344
Additional Work (new agreement, FAR part 6 applies) P00009 $3,616,950
Exercise an Option P00008 · "covid-19". To provide a broad range of clinical and other related research support services for niaid/daids-supported clinical research portfolio and other… $627,769
Other Administrative Action P00007 · R & D- medical: aids research (basic research) $0
Exercise an Option P00006 $9,017,561
Other Administrative Action P00005 $0
Funding Only Action 4 -$603,386
Exercise an Option 3 $8,845,324
Exercise an Option 2 $373,410
Exercise an Option 1 $229,976
Original award Niaid HIV and other infectious diseases clinical research support services (CRSS) $8,644,838
Show all 32

About this award

Written by GovTribe AI ·

This is a $332,437,171.79 cost-plus-award-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization, for clinical research support services related to HIV and other infectious diseases. The contract has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2017.

The original federal contract opportunity was a sources sought notice to discern if there were other contractors, including small or small disadvantaged businesses, capable of and interested in performing the work. The notice indicated the complexity and quantity of requirements for support services for the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)-2 program had significantly increased, with over 300% increases in the number of clinical trial sites, screened patients, and enrolled/completed patients, as well as increases in monitoring requirements. As a result, NIAID may issue a Request for Proposals if deemed necessary and appropriate.

This is a large single-award indefinite delivery vehicle contract that allows PPD Development LP to provide a broad spectrum of clinical trial and research support services to NIAID across various therapeutic areas. The company has extensive experience supporting federal medical research initiatives and holds several significant federal contract vehicles.

Quick answers

Who was awarded contract HHSN272201700078C?

HHSN272201700078C was awarded to PPD Development LP by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 14, 2017.

How much is contract HHSN272201700078C worth?

The government has obligated $329,835,681 on HHSN272201700078C. Its potential value, with all options, is $332,437,172.

Was contract HHSN272201700078C competed?

The extent of competition for HHSN272201700078C was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login